Literature DB >> 48836

Use of co-trimoxazole in chronic renal failure.

P R Tasker, G A MacGregor, H E de Wardener.   

Abstract

Twenty patients with chronic renal failure and either urinary or respiratory tract infection were treated with co-trimoxazole. Seventeen patients showed no deterioration in renal function while receiving co-trimoxazole. Deterioration in renal function during treatment in the other three patients was due to factors other than administration of the drug. It is concluded that co-trimoxazole can be used in patients with chronic renal failure provided the dose is adjusted according to the degree of renal failure.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 48836     DOI： 10.1016/s0140-6736(75)92196-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  Clinical Pharmacology of Antibiotics.

Authors:  Rachel F Eyler; Kristina Shvets
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-12       Impact factor: 8.237

2.  The effect of co-trimoxazole on serum creatinine.

Authors:  B A Dijkmans; J P van Hooff; F A de Wolff; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

3.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

4.  [Effect of Co-trimoxazole on renal creatinine excretion in man (author's transl)].

Authors:  M Bräutigam; P Froese; R Baethke; M Kessel
Journal:  Klin Wochenschr       Date:  1979-01-15

Review 5.  Drug-induced renal disease.

Authors:  J R Curtis
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

6.  Deterioration of kidney function by high doses of co-trimoxazole in man.

Authors:  T B Vree; M Martea; Y A Hekster; E F Termond; R Van Klaveren; J W Lammers; J H Berden
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

7.  Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.

Authors:  E Singlas; J N Colin; J Rottembourg; J P Meessen; A de Martin; M Legrain; P Simon
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.

Authors:  Hiroyuki Takita; Daniel Scotcher; Rajkumar Chinnadurai; Philip A Kalra; Aleksandra Galetin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.